Results 261 to 265 of about 50,773 (265)

Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

Journal of the American Academy of Dermatology
Natasha A Mesinkovska, Matthew Zirwas
exaly  

Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review

Journal of the American Academy of Dermatology
Ahmed Bagit, Khalad Maliyar, Siddhartha Sood   +2 more
exaly  

Response to Sood et al’s “Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review”

Journal of the American Academy of Dermatology
Caitlin A Kearney, Carli D Needle, Anna L Brinks   +2 more
exaly  

Bone Erosion Repair With a Janus Kinase Inhibitor

The Journal of Rheumatology
Daiki Nakagomi, Shunichiro Hanai
openaire   +2 more sources

Janus kinase inhibitors battle in the heavyweight class

Journal of the American Academy of Dermatology
openaire   +2 more sources